Skip to main content
Veterinary Medicines

Ralcam, 100+0,05mg/ml, Solution for injection

Authorised
  • Cyanocobalamin
  • Butafosfan

Product identification

Medicine name:
Ralcam, 100+0,05mg/ml, Solution for injection
Catobevit 100 mg/ml + 0.05 mg/ml Injektionslösung für Rinder
Active substance:
  • Cyanocobalamin
  • Butafosfan
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Cyanocobalamin
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Butafosfan
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Glass Vial 1 x 250.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402646.00.00
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0160/001
Concerned member states:
  • Germany

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (RTF)
Published on: 3/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (RTF)
Published on: 3/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."